ArticleKidney3602026

Diabetic Ketoacidosis Risk in Sodium-Glucose Cotransporter 2 Inhibitors versus Glucagon-Like Peptide-1 Receptor Agonists Initiators with CKD Stages 3-4 and Type 2 Diabetes.

Panupong Hansrivijit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.